In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
The bacterial CRISPR/Cas system has proven to be an efficient tool for genetic manipulation in various organisms. Here we show the application of CRISPR-Cas9 technology to edit the human Rhodopsin (RHO) gene in a mouse model for autosomal dominant Retinitis Pigmentosa. We designed single or double s...
Saved in:
Main Authors: | Maria Carmela Latella (Author), Maria Teresa Di Salvo (Author), Fabienne Cocchiarella (Author), Daniela Benati (Author), Giulia Grisendi (Author), Antonella Comitato (Author), Valeria Marigo (Author), Alessandra Recchia (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subcellular localization of mutant P23H rhodopsin in an RFP fusion knock-in mouse model of retinitis pigmentosa
by: Michael A. Robichaux, et al.
Published: (2022) -
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
by: Ahmed Salman, et al.
Published: (2022) -
Plasmid DNA Delivery into the Skin via Electroporation with a Depot-Type Electrode
by: Yuya Yoshida, et al.
Published: (2024) -
Poly(Beta-Amino Ester) Nanoparticles Enable Nonviral Delivery of CRISPR-Cas9 Plasmids for Gene Knockout and Gene Deletion
by: Yuan Rui, et al.
Published: (2020) -
Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies
by: Debnath Maji, et al.
Published: (2024)